Conference Coverage

DNA vaccine + PD-1 blockade shows promise in mCRPC

NATIONAL HARBOR, MD. – Combining PD-1 pathway inhibition with a DNA vaccine led to antitumor changes in mCRPC patients in a randomized clinical...